12/11/2024  21:43:33 Var. -8.100 Volume Denaro21:59:59 Lettera21:59:59 Capitalizzazione di mercato Dividend Y. Rapporto P/E
403.400EUR -1.97% 67
Fatturato: 27,355.500
400.900Quantità in denaro: 37 401.500Quantità in lettera: 37 32.85 bill.EUR - -

Descrizione business

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in more than 175 countries.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Jay Mazelsky
Consiglio di amministrazione
Brian P. McKeon, Irene Chang Britt, Michael Lane, James F. Polewaczyk, Martin Smith, Sharon E. Underberg, Michael P. Johnson, Kerry Bennett, Mike Erickson, George J. Fennell, Ken Grady, John Hart, Dan Janson, Michael Schreck, Murthy Yerramilli
Consiglio di sorveglianza
Lawrence D. Kingsley, Bruce L. Claflin, Daniel M. Junius, Dr. Asha S. Collins, Dr. Sophie V. Vandebroek, Dr. Stuart M. Essig, Jay Mazelsky, Jonathan W. Ayers, M. Anne Szostak, Sam Samad, Irene Chang Britt
 

Dati aziendali

Name: IDEXX Laboratories Inc.
Indirizzo: One IDEXX Drive,Westbrook, Maine 04092, USA
Telefono: +1-207-556-0300
Fax: +1-207-556-4346
E-mail: -
Internet: www.idexx.com
Industria: Biotechnology
Settore: Biotechnology
Sub settore: Biotechnology
Fine dell'anno finanziario: 31/12
Flottante libero: 57.24%
Data dell'IPO: 21/06/1991

Rapporti con gli investitori

Name: John Ravis
IR telefono: +1-207-556-8155
IR Fax: +1-207-556-4427
IR e-mail: investorrelations@idexx.com

Principali azionisti

Altri
 
57.36%
BlackRock Inc.
 
10.96%
Vanguard Group
 
10.14%
State Street Corporation
 
4.57%
ALLIANCEBERNSTEIN L P
 
3.56%
Fundsmith LLP
 
3.30%
BAMCO INC NY
 
2.79%
GEODE CAPITAL MANAGEMENT LLC
 
2.55%
Franklin Resources Inc.
 
1.70%
Altri
 
3.06%